Abstract
There are many conceptual ways to consider the devices intended to support the circulation: the indication for implantation, type of device, the ventricles supported, the anticipated duration of support and the acuity of patient need. For example, devices used to support a patient in cardiogenic shock following an acute myocardial infarction are different from those used to treat a patient in chronic advanced heart failure who will live permanently on a device. In the remainder of this chapter, mechanical circulatory support devices will be presented as those intended for either short- or long-term support.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Trost JC, Hillis LD. Intra-aortic balloon counterpulsation. Am J Cardiol. 2006;97:1391–8.
Santa-Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: a review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv. 2006;67:68–77.
Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM. For the investigators in the National Registry of myocardial infarction 2. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complication acute myocardial infarction: data from the National Registry of myocardial infarction 2. Am Heart J. 2001;141:933–9.
Stone GW, Marsalese D, Brodie BR, Griffin JJ, Donohue B, Costantini C, Balestrini C, Wharton T, Esenta P, Spain M, Moses J, Nobuyoshi M, Ayres M, Jones D, Mason D, Grines L, O’Neill WW, Grines C. A prospective, randomized evaluation of prophylactic intra-aortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997;29:1459–67.
Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287–96.
Estep JD, Cordero-Reyes AM, Bhimaraj A, Trachtenberg B, Khalil N, Loebe M, Bruckner B, Orrego CM, Bismuth J, Kleiman NS, Torre-Amione G. Percutaneous placement of an intra-aortic balloon pump in the left axillary/subclavian position provides safe, ambulatory long-term support as bridge to heart transplantation. JACC Heart Fail. 2013;1:382–8.
Lima B, Kale P, Gonzalez-Stawinski GV, Kuiper JJ, Carey S, Hall S. Effectiveness and safety of the Impella 5.0 as a bridge to transplantation or durable left ventricular assist device. Am J Cardiol. 2016;117:1622–8.
O’Neill WW, Kleiman BS, Moses J, et al. A prospective randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention. The PROTECT II study. Circulation. 2012;126:1717–27.
Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJS, Vis MM, Wykrzkowska JJ, Koch KT, Baan J, de Winter RJ, Piek JJ, Lagrand WK, de Mol B, Tijssen JGP, Henriques JPS. Impella CP versus intra-aotic balloon pump in acute myocardial infarction complicated by cardiogenic shock: The IMPRESS trial. J Am Coll Cardiol. 2016; ePub ahead of print.
Ouweneel DM, Eriksen E, Seyfarth M, Henriques JPS. Impella versus intra-aortic balloon pump for the treatment of cardiogenic shock: a meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2016; ePub ahead of print.
Griffith BP, Anderson MB, Samuels LE, et al. The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support. J Thorac Cardiovasc Surg. 2013;145:548–54.
Anderson MB, Goldstein J, Milano CA, Morris LD, Kormos RL, Bhama J, Kapur NK, Bansal A, Garcia J, Baker JN, Silvestry S, Holman WL, Douglas PS, O’Neill W. Benefits of a novel percutaneous ventricular assist device for the right heart: the prospective RECOVER RIGHT study of the IMPELLA RP device. J Heart Lung Transplant. 2015;34:1549–60.
Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011;57:688–96.
Allen S, Holena D, McCunn M, Kohl B, Sarani B. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically III adult patients. J Intensive Care Med. 2011;26:13–26.
Bougouin W, Aissaoui N, Combes A, Deye N, Lamhaut L, Jost D, Maupain C, Beganton F, Bougle A, Karam N, Dumas F, Marijon E, Jouven X, Cariou A, on behalf SDEC Investigators. Post-cardiac arrest shock treated with veno-arterial extracorporeal membrane oxygenation An observational study and propensity analysis. Resuscitation. 2017;110:126–32.
Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaroonson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.
Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.
Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, Kasirijan V, Haas DC, O’Connell JB, Boyle AJ, Farrar DJ, Rogers JG. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients. J Am Coll Cardiol. 2015;66:1747–61.
Netuka I, Sood P, Pya Y ZD, Krabatsch T, Gaargade J, Rao V, Morshuis M, Marasco S, Beyersdorf J, Damme L, Schmitto JD. Fully magnetically levitated left ventricular assist system for treating advanced heart failure. J Am Coll Cardiol. 2015;66:2579–89.
Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC, Colombo PC, Walsh MN, Milarno CA, Patel CB, Jorde UP, Pagani FD, Aaronson KD, Dean DA, McCants K, Itoh A, Ewald GA, Horstmanshof D, Long JW, Salerno C. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2016; ePub ahead of print.
Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, Jessup ML, Gregoric ID, Loyalka P, Frazier OH, Jeevanandam V, Anderson AS, Kormos RL, Teuteberg JJ, Levy WC, Naftel DC, Bittman RM, Pagani FD, Hathaway DR, Boyce SW, for the HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125:3191–200.
Rogers JG, Pagani FD, Tatooles AJ, Bhat G, Slaughter MS, Birks EJ, Boyce SW, Najjar SS, Jeevanandam V, Anderson AS, Gregoric ID, Mallidi H, Leadley K, Aaronson KD, Frazier OH, Milano CAIntra-pericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451–60.
Teuteberg JJ, Slaughter MS, Rogers JG, McGee EC, Pagani FD, Gordon R, Rame E, Acker M, Kormos RL, Salerno C, Schleeter TP, Goldstein DJ, Shin J, Starling RC, Wozniak T, Malik AS, Silvestry S, Ewald GA, Jorde UP, Naka Y, Birks E, Najarian KB, Hathaway DR, Aaronson KD, for the ADVANCE Investigators. The HVAD left ventricular assist device. Risk factors for neurological events and risk mitigation strategies. JACC Heart Fail. 2015;3:818–28.
Fraser CD, Jaquiss R, Rosenthal DN, Humpl T, Canter CE, Blackstone EH, Naftel DC, Ichord RN, Bomgaars L, Tweddell JS, Massicotte P, Turrentine MW, Cohen GA, Devaney EJ, Pearce FB, Carberry KE, Kroslowitz R, Almond CS, for the Berlin Heart Study Investigators. Prospective trial of a pediatric ventricular assist device. N Engl J Med. 2012;367:532–41.
Mohacsi P, Leprince P. The CARMAT total artificial heart. Eur J Cardiothorac Surg. 2014;46:933–4.
Goerlich CE, Frazier OH, Cohn WE. Previous challenges and current progress – the use of total artificial heart in patients with end-stage heart failure. Expert Rev Cardiovasc Ther. 2016;14:1095–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rogers, J.G. (2019). Types of Circulatory Support Devices. In: Feldman, D., Mohacsi, P. (eds) Heart Failure. Cardiovascular Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-98184-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-319-98184-0_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98182-6
Online ISBN: 978-3-319-98184-0
eBook Packages: MedicineMedicine (R0)